Cargando…
Drotrecogin alpha: a rational approach to the treatment of submassive pulmonary embolism?
Combining therapeutic doses of low-molecular-weight heparins and increasing doses of recombinant activated protein C - Drotrecogin alpha (activated), or DAA - is of theoretical interest with regard to the control of coagulation activation. The study by Dempfle and colleagues presents new data showin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221987/ https://www.ncbi.nlm.nih.gov/pubmed/21345242 http://dx.doi.org/10.1186/cc10027 |